LianBio

Takeda, WuXi, LianBio—Fierce Pharma Asia

Takeda finally won an FDA nod for Eohilia. U.S. lawmakers want sanctions against WuXi for national security reasons. LianBio will shut down. Plus more.

Angus Liu Feb 16, 2024 8:24am

WuXi, Daiichi-Novartis, Merck KGaA-Abbisko—Fierce Pharma Asia

Dec 8, 2023 8:13am

Merck-Daiichi, Kelun, AstraZeneca—Fierce Pharma Asia

Oct 27, 2023 9:10am

Bristol Myers scoops up Asian rights to Camzyos for $350M

Oct 24, 2023 11:03am

BridgeBio partner Helsinn pulls Truseltiq for 'business reasons'

Oct 13, 2022 12:54pm